Skip to content
    Wellington Management logo

    Wellington Management

    Boston, Massachusetts, United StatesFounded 1928

    Wellington Management's venture capital strategy focuses on investing across the business lifecycle, from early-stage venture to late-stage growth, in industry-defining entrepreneurs and changemakers. Their investment focus spans sectors such as B2B software, fintech, consumer technology, artificial intelligence, digital health, biotechnology, and climate technology, with a particular emphasis on supporting historically underrepresented founders.

    Average disclosed round size is $300.3M (across 116 rounds with reported amounts).

    Find people at Wellington Management on Goldilocks AI

    Portfolio

    117

    Fund Size

    $150M

    Top Stage

    Series B

    Last 12 Mo

    14

    Team

    AR

    Amar Reganti

    Managing Director - Fixed Income Strategy and Global Insurance Strategy

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    117 investments
    CompanyRoundAmountDate
    Quince logoQuinceSeries E$500MMar 2026
    Encord logoEncordSeries C$60MFeb 2026
    Nnyra healthSeries A$20MFeb 2026
    Forerunner logoForerunnerSeries B$26.3MFeb 2026
    Jelou logoJelouSeries A$10MJan 2026
    Crisp logoCrispSeries B$26MDec 2025
    Flex logoFlexSeries B$60MDec 2025
    Cactus logoCactusSeed$7MNov 2025
    Tubulis logoTubulisSeries C$308MOct 2025
    Keychain logoKeychainSeries B$30MAug 2025
    SSNIPR BiomeSeries B$35MAug 2025
    Crescent Biopharma logoCrescent BiopharmaGrowth$200MJun 2025
    AAktiia (rebranding to Hilo)Series B$37MMay 2025
    HHiloSeries B$42MMay 2025
    tabby logotabbySeries E$160MFeb 2025
    AArcher AviationGrowth$300MFeb 2025
    Helicore Biopharma Inc. logoHelicore Biopharma Inc.Series A$65MJan 2025
    Databricks logoDatabricksGrowth$10BDec 2024
    Aignostics logoAignosticsSeries B$34MOct 2024
    TTrace MachinaSeed$4.7MAug 2024
    TTS Conductor Corp.Series C$60MJul 2024
    SciRhom GmbH logoSciRhom GmbHSeries A$70MJul 2024
    UroMems logoUroMemsSeries C$47MJun 2024
    Scale AI logoScale AIGrowth$1BMay 2024
    Bluejay Therapeutics logoBluejay TherapeuticsSeries C$182MMay 2024
    Page 1 of 5

    Top Co-Investors

    Last updated: 10 April 2026